<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Increases in the prevalence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> of 30-60% will occur in many Asian-Pacific countries by 2025, driven by urbanisation, sedentary habits and energy-rich diets </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001513'>Obesity</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp> are closely interrelated </plain></SENT>
<SENT sid="2" pm="."><plain>Optimal control of <z:mp ids='MP_0002055'>diabetes</z:mp> and associated risk factors has reduced the risk of <z:mp ids='MP_0002055'>diabetes</z:mp>-related complications </plain></SENT>
<SENT sid="3" pm="."><plain>In the UK Prospective <z:mp ids='MP_0002055'>Diabetes</z:mp> Study (UKPDS), <z:chebi fb="0" ids="6801">metformin</z:chebi> reduced the risk of macrovascular complications and retrospective analyses have confirmed the efficacy of <z:chebi fb="0" ids="6801">metformin</z:chebi> in improving clinical outcomes in type 2 diabetic patients with a history of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>This growing body of evidence has led to the recommendation of <z:chebi fb="0" ids="6801">metformin</z:chebi> as optimum initial pharmacotherapy in overweight type 2 diabetic patients </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001513'>Obesity</z:hpo> is less prevalent in the Asian-Pacific population than in Caucasian populations </plain></SENT>
<SENT sid="6" pm="."><plain>Nevertheless, <z:chebi fb="0" ids="6801">metformin</z:chebi> has multiple beneficial metabolic effects, which provide sufficient rationale for it to be recommended as the initial oral anti-diabetic pharmacotherapy, alone or in combination, irrespective of body mass index </plain></SENT>
<SENT sid="7" pm="."><plain>This recommendation is consistent with global guidelines and regional recommendations for the Asian-Pacific region from the International <z:mp ids='MP_0002055'>Diabetes</z:mp> Federation </plain></SENT>
<SENT sid="8" pm="."><plain>These recommendations can serve as templates for development of local guidelines for Asian people with <z:mp ids='MP_0002055'>diabetes</z:mp>, given the ethnic and cultural diversity within the region </plain></SENT>
</text></document>